# Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms

> **NCT00529269** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 200 (estimated)

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** Enteric-Coated Mycophenolate Sodium (EC-MPS)

## Key facts

- **NCT ID:** NCT00529269
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-06
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00529269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00529269, "Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00529269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*